Article

Hyperoxia and Hypoxia in Children Resuscitated From Cardiac Arrest

1 Department of Pediatrics, Division of Pediatric Emergency Medicine, University of Pittsburgh School of Medicine and the Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA. 2 Division of Critical Care Medicine, University of Pittsburgh School of Medicine and the Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 3 Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine and the Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA.
Pediatric Critical Care Medicine (Impact Factor: 2.33). 02/2013; 14(3). DOI: 10.1097/PCC.0b013e3182720440
Source: PubMed

ABSTRACT BACKGROUND:: Ischemia depletes antioxidant reserves and impairs mitochondrial electron transport. Oxygen within blood reperfusing ischemic tissue can form free radicals, worsen oxidative stress, and exacerbate tissue injury (reperfusion injury). One strategy for limiting reperfusion injury is to limit delivery of "luxuriant" oxygen during or after reperfusion. Resuscitation guidelines for children with cardiac arrest recommend early weaning of supplemental oxygen as tolerated. There are currently no studies demonstrating the frequency and outcomes of hyperoxia and hypoxia after pediatric cardiac arrest. OBJECTIVE:: To determine the frequency and outcomes of hyperoxia and hypoxia in patients following resuscitation from pediatric cardiac arrest admitted to a tertiary care center. DESIGN AND METHODS:: This is a retrospective observational cohort study. Charts of children resuscitated from cardiac arrest and admitted to our hospital from 2004 to 2008 were reviewed. Partial pressures of oxygen (PaO2) obtained within the first 24 hrs following return of spontaneous circulation and mortality at 6 months was recorded. Children who did not survive the initial 48 hrs, patients having undergone extracorporeal oxygenation or had congenital heart disease, and those in whom arterial blood gases were not obtained were excluded. RESULTS:: Seventy-four patients met inclusion criteria. Of these, 38 (51%) had at least one arterial blood gases with a PaO2 > 300 mm Hg and 10 (14%) had a PaO2 < 60 mm Hg in the first 24 hrs. Neither hyperoxia nor hypoxia on initial arterial blood gases (p = 0.912 and p = 0.384) nor any arterial blood gases within the first 24 hrs after cardiac arrest (p = 0.325 and p = 0.553) was associated with 6-month mortality. CONCLUSIONS:: Hyperoxia occurs commonly within the first 24 hrs of management in children resuscitated from cardiac arrest.

Full-text

Available from: Ericka L Fink, May 12, 2014
2 Followers
 · 
105 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study is to review the recent literature describing how to assess and treat postcardiac arrest syndrome associated haemodynamics and manage oxygenation and ventilation derangements. Postcardiac arrest syndrome is a well described entity that includes systemic ischemia-reperfusion response, myocardial dysfunction and neurologic dysfunction. Continued resuscitation in the hours to days following return of spontaneous circulation (ROSC) is important to increase the likelihood of long-term survival and neurological recovery. Post-ROSC hypotension is common and associated with worse outcome. Myocardial dysfunction peaks in the first 24 h following ROSC and in survivors resolves over the next few days. Hyperoxemia (paO2 >300 mmHg) and hypoxemia (paO2 <60 mmHg) are associated with worse outcomes and hyperventilation may exacerbate cerebral ischemic injury by decreasing cerebral oxygenation. Patients who are successfully resuscitated from cardiac arrest often have hypotension and myocardial dysfunction. Careful attention to haemodynamic and ventilator management targeting normal blood pressure, normoxemia and normocapnia may help to avoid secondary organ injury and potentially improve outcomes.
    Current opinion in critical care 04/2015; DOI:10.1097/MCC.0000000000000205 · 3.18 Impact Factor
  • Critical care medicine 11/2013; 41(11):e393. DOI:10.1097/CCM.0b013e3182a266ec · 6.15 Impact Factor
  • Critical care medicine 11/2013; 41(11):e392-3. DOI:10.1097/CCM.0b013e31829e4e1f · 6.15 Impact Factor